Xenon and Merck Collaborate on Cardiovascular Disease Treatment
By Taskin Ahmed
PharmaDeals Review: Vol 2009 Issue 7 (Table of Contents)
Published: 2 Jul-2009
DOI: 10.3833/pdr.v2009i7.1129 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Xenon Pharmaceuticals announced an alliance with Merck & Co to develop novel candidates for the treatment of cardiovascular disease treatment...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS